Preliminary consolidated results of JSC Olainfarm for March 2014 show that sales have reached the level of 6.41 million euro, which represent an increase by 35% compared to the same period one year ago. The biggest sales increases were achieved in Ukraine, where sales grew by 1893%, while sales to Lithuania grew by 248%, sales to Tajikistan by 69%, sales to Belarus by 52% and sales to Latvia by 51%. Major sales markets of JSC Olainfarm in March 2014 were Russia, Latvia, Ukraine and Belarus. Significant shipments during this period have also been made to Uzbekistan, The Netherlands and Albania.
| March 2014, consolidated sales | Share in total sales | Changes to March 2013 |
| Russia | 32% | -2% |
| Latvia | 27% | 51% |
| Ukraine | 13% | 1893% |
| Belarus | 10% | 52% |
| Kazakhstan | 3% | -51% |
| Uzbekistan | 3% | NA |
| The Netherlands | 2% | NA |
| Tajikistan | 2% | 69% |
| Albania | 2% | NA |
| Lithuania | 2% | 248% |
| Other | 6% | -35% |
| Total | 100% | 35% |
During the first three months of 2013, according to preliminary figures consolidated sales of JSC Olainfarm were 23.44 million euro, which represents an increase by 37% compared to the same period of 2013. The most rapid sales increase during this period was achieved in Spain, where sales grew by 181%. Sales to Lithuania grew by 171% but sales to Ukraine grew by 157%. Major sales markets of JSC Olainfarm during first three months of 2014 were Russia, Latvia, Ukraine, Belarus, The Netherlands and the UK.
Sales of pharmacy chain Ltd. Latvijas aptieka, owned by JSC Olainfarm in March 2014 were 1.32 million euro. There were 54 pharmacies operating in March. Sales of Ltd. Silvanols in March were 0.27 million euro.
| 3 months of 2014, consolidated sales | Share in total sales | Changes to 3 months of 2013 |
| Russia | 34% | 0% |
| Latvia | 23% | 29% |
| Ukraine | 13% | 157% |
| Belarus | 10% | 47% |
| The Netherlands | 4% | NA |
| UK | 4% | 2% |
| Uzbekistan | 2% | 67% |
| Kazakhstan | 1% | -50% |
| Spain | 1% | 181% |
| Lithuania | 1% | 171% |
| Other | 8% | 401% |
| Total | 100% | 37% |
During the first three months of 2014 sales of chain of pharmacies Ltd. Latvijas aptieka owned by JSC Olainfarm were 3.84 million euros, while sales of Ltd. Silvanols in this period were 0.86 million euros.
According to unconsolidated preliminary sales results of JSC Olainfarm for March 2014, the sales in this period were 5.31 million euro, which represents an increase by 28% compared to the same period of 2013. The biggest sales increase was achieved in Ukraine, where sales grew by 1893%. Sales to Lithuania grew by 186%, sales to Tajikistan grew by 69% but sales to Belarus grew by 52%. In March significant shipments were also made to Uzbekistan, The Netherlands and Albania. Major sales markets of JSC Olainfarm in March 2014 were Russia, Ukraine, Latvia and Belarus. In total during March JSC Olainfarm made sales to 19 countries in three continents.
| March 2014, unconsolidated sales | Share in total sales | Changes to March 2013 |
| Russia | 39% | -2% |
| Ukraine | 15% | 1893% |
| Latvia | 14% | 34% |
| Belarus | 12% | 52% |
| Kazakhstan | 3% | -51% |
| Uzbekistan | 3% | NA |
| The Netherlands | 3% | NA |
| Tajikistan | 2% | 69% |
| Albania | 2% | NA |
| Lithuania | 1% | 186% |
| Other | 6% | -50% |
| Total | 100% | 28% |
During the first three months of 2014, according to preliminary results, unconsolidated sales of JSC Olainfarm were 20.01 million euro, which represents an increase by 30% compared to the same period of 2013. The most rapid sales increases during these three months have been achieved in Spain and Ukraine, where sales grew by 181% and 157% respectively. Per order of the Who, significant sales have also been made to The Netherlands. According to preliminary unaudited results the major sales markets of JSC Olainfarm during three months of 2014 were Russia, Ukraine, Belarus, Latvia, The Netherlands and the UK. In total during three months of 2014 products of JSC Olainfarm were sold to 31 countries in five continents.
| 3 months of 2014, unconsolidated sales | Share in total sales | Changes to 3 months of 2013 |
| Russia | 40% | 0% |
| Ukraine | 15% | 157% |
| Belarus | 12% | 47% |
| Latvia | 11% | 32% |
| The Netherlands | 4% | NA |
| UK | 4% | 2% |
| Uzbekistan | 2% | 67% |
| Kazakhstan | 2% | -50% |
| Spain | 1% | 181% |
| Italy | 1% | -13% |
| Other | 8% | 74% |
| Total | 100% | 30% |
According to preliminary estimates, unconsolidated sales of JSC Olainfarm could reach 80 million euro, while consolidated sales could reach 90 million euro. According to these preliminary sales figures, during three months of 2014, 25% of annual target for unconsolidated and 26% of annual target for consolidated sales have been achieved.
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by JSC Olainfarm are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv
